Your browser doesn't support javascript.
loading
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
Richardson, Debra L; Sill, Michael W; Coleman, Robert L; Sood, Anil K; Pearl, Michael L; Kehoe, Siobhan M; Carney, Michael E; Hanjani, Parviz; Van Le, Linda; Zhou, Xun C; Alvarez Secord, Angeles; Gray, Heidi J; Landrum, Lisa M; Lankes, Heather A; Hu, Wei; Aghajanian, Carol.
Afiliação
  • Richardson DL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas.
  • Sill MW; NRG Oncology Statistics & Data Management Center, Roswell Park Cancer Institute, Buffalo, New York.
  • Coleman RL; University of Texas, MD Anderson Cancer Center, Houston.
  • Sood AK; University of Texas, MD Anderson Cancer Center, Houston.
  • Pearl ML; Division of Gynecological Oncology, Stony Brook University Hospital, Health Sciences Center T9, Stony Brook, New York.
  • Kehoe SM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas.
  • Carney ME; University of Hawaii, Women's Cancer Center, Honolulu.
  • Hanjani P; Hanjani Institute for Gynecologic Oncology, Abington Memorial Hospital, Abington, Pennsylvania.
  • Van Le L; Department of Obstetrics & Gynecology, University of North Carolina at Chapel Hill, Chapel Hill.
  • Zhou XC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Hospital of Central Connecticut, New Britain.
  • Alvarez Secord A; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Medical Center, Durham, North Carolina.
  • Gray HJ; University of Washington Medical Center, Seattle.
  • Landrum LM; Department of Obstetrics and Gynecology, Oklahoma University Health Science Center, Oklahoma City.
  • Lankes HA; NRG Oncology Statistics & Data Management Center, Roswell Park Cancer Institute, Buffalo, New York.
  • Hu W; University of Texas, MD Anderson Cancer Center, Houston.
  • Aghajanian C; Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
JAMA Oncol ; 4(2): 196-202, 2018 Feb 01.
Article em En | MEDLINE | ID: mdl-29242937
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Pirimidinas / Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Carcinoma Epitelial do Ovário / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Pirimidinas / Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Carcinoma Epitelial do Ovário / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article